Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma

Tristan Knight; Margaret Shatara; Lindsey Carvalho; Deniz Altinok; Janet Poulik; Zhihong Joanne Wang

doi:10.1002/pbc.27474

Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma

Tristan Knight, Margaret Shatara, Lindsey Carvalho, Deniz Altinok, Janet Poulik, Zhihong Joanne Wang

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	e27474
Journal	Pediatric Blood and Cancer
Volume	66
Issue number	1
DOIs	https://doi.org/10.1002/pbc.27474
State	Published - Jan 2019

Keywords

MEK inhibitor
low-grade glioma
neurofibromatosis type 1
trametinib

Access to Document

10.1002/pbc.27474

Cite this

@article{988dcd9fc9a344c19b80d5cb71015728,

title = "Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma",

keywords = "MEK inhibitor, low-grade glioma, neurofibromatosis type 1, trametinib",

author = "Tristan Knight and Margaret Shatara and Lindsey Carvalho and Deniz Altinok and Janet Poulik and Wang, {Zhihong Joanne}",

year = "2019",

month = jan,

doi = "10.1002/pbc.27474",

language = "English",

volume = "66",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

number = "1",

}

TY - JOUR

T1 - Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma

AU - Knight, Tristan

AU - Shatara, Margaret

AU - Carvalho, Lindsey

AU - Altinok, Deniz

AU - Poulik, Janet

AU - Wang, Zhihong Joanne

PY - 2019/1

Y1 - 2019/1

KW - MEK inhibitor

KW - low-grade glioma

KW - neurofibromatosis type 1

KW - trametinib

UR - http://www.scopus.com/inward/record.url?scp=85053734855&partnerID=8YFLogxK

U2 - 10.1002/pbc.27474

DO - 10.1002/pbc.27474

M3 - Letter

C2 - 30251337

AN - SCOPUS:85053734855

SN - 1545-5009

VL - 66

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 1

M1 - e27474

ER -

Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma

Keywords

Access to Document

Other files and links

Cite this